Bimekizumab for treating axial spondyloarthritis

Equality Impact Assessment (Guidance development) (PDF 145 KB)

Register of interests (PDF 126 KB)

Final draft guidance

Final draft guidance (PDF 167 KB)

Committee papers (PDF 8.67 MB)

Final scope (PDF 247 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 294 KB)

Final stakeholder list (PDF 166 KB)

Equality impact assessment (Scoping) (PDF 125 KB)